For informational purposes only — not investment advice

← Back to signals

COMP

LONGINSIDER SELL

COMPASS INC

Research: Finviz ↗·Perplexity ↗

🗄 Viewing archived Q2 2026 data — frozen, no longer refreshed.

Funds
3
Score
2.50
vs SPY
-16.9%
Stock return (since Q-end)
-17.5%
SPY return (since Q-end)
-0.7%
Current price
$10.17
Days to cover (short int.)
3.0d↑+4.4%
as of 2026-09-30 · shares short vs 2026-06-30

News Summary

Positive

Compass delivered record Q3 2026 results with 12% YoY revenue growth, $62M net income, and $841M cash balance post-Anywhere merger integration, demonstrating successful execution. However, the company faces a securities class action lawsuit tied to merger disclosures and mixed analyst sentiment with price target cuts from UBS, partially offsetting upgrade actions from Zelman and Citizens.

Red flags

  • •Securities class action lawsuit filed regarding Anywhere merger disclosures with lead plaintiff deadline December 8, 2026
  • •CEO insider stock sales of $841,663 under 10b5-1 trading plan (routine but notable timing during merger integration and litigation exposure)
  • •UBS price target cut from $17.00 to $15.00 suggests analyst de-rating despite operational performance

Funds Buying (3)

FundManagerShares Held∆ SharesPosition Value% of FundQoQStatus
D1 CapitalDan Sundheim15.2M+15.2M$188M0.5%—NEW
Maverick CapitalLee Ainslie5.9M+740K$73M0.7%+14%Existing
Point72Steve Cohen877K+877K$11M<0.1%—NEW

Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.

Portfolio Context

Where COMP ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.

D1 Capital

position #29 of this fund's book

  1. 26CAPITAL ONE FINL CORP$219M
  2. 27LINEAGE INC$205M
  3. 28MARTIN MARIETTA MATLS INC$199M
  4. 29COMPASS INC$188M
  5. 30COUPANG INC$179M
  6. 31LINDE PLC$177M
  7. 32TESLA INC$169M
Maverick Capital

position #40 of this fund's book

  1. 37MIRION TECHNOLOGIES INC$94M
  2. 38VAXCYTE INC$94M
  3. 39NOVO-NORDISK A S$79M
  4. 40COMPASS INC$73M

Values are quarter-end position sizes. Shown only for funds where COMP ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.

Insider Activity

NameTitleTypeSharesPriceValueFiledSrc
Reffkin Robert L.Chairman and CEOSELL83K$10.10$0.84M2026-11-11↗
Reffkin Robert L.Chairman and CEOSELL19K$10.10$0.19M2026-11-11↗
Reffkin Robert L.Chairman and CEOSELL23K$11.70$0.27M2026-08-03↗
Reffkin Robert L.Chairman and CEOSELL23K$12.51$0.29M2026-07-01↗

Beneficial Ownership (13D/13G)

FilerFormShares% of ClassFiledSrc
Vanguard Capital ManagementSC 13G37.6M5.0%2026-07-31↗
BlackRock, Inc.SC 13G/A52.5M7.0%2026-07-27↗
FMR LLCSC 13G/A107.4M14.5%2026-05-06↗
Vanguard Portfolio ManagementSC 13G60.5M8.2%2026-04-29↗

SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.